Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 11, 2002, Pages 4946-4951

  Nakchbandi, Inaam A ^a,b,c   Mitnick, Mary Ann ^a,b,c   Lang, Robert ^a,b,c   Gundberg, Caren ^a,b,c   Kinder, Barbara ^a,b,c   Insogna, Karl ^a,b,c  

^a Section of Endocrinology   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Osteoporosis Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; DISEASE ACTIVITY; FEMALE; FEMUR; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OSTEOLYSIS; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; BIOLOGICAL MARKERS; BONE REMODELING; BONE RESORPTION; CALCITRIOL; CALCIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; FEMUR; HUMANS; HYPERPARATHYROIDISM; INTERLEUKIN-6; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-6;

EID: 0036847022     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-011814     Document Type: Article

References (24)

1. Silverberg S, Shane E, Jacobs TP, Siris E, Bilezikian JP 1999 A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249-1255
2. Guo C, Thomas W, Al-Dehaimi A, Assiri A, Eastell R 1996 Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 81:3487-3491
3. Grey A, Stapleton J, Evans M, Tatnell M, Reid I 1996 Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 125:360-368
4. Khosla S, Melton L, Wermers R, Crowson C, O'Fallon W, Riggs B 1999 Primary hyperparathyroidism and the risk of fracture: A population-based study. J Bone Miner Res 14:1700-1707
5. Vestergaard P, Mollerup C, Frokjaer V, Christiansen P, Blichert-Toft M, Mosekilde L 2000 Cohort study of risk of fracture before and after surgery for primary hyperparathyroidisrn. BMJ 321:598-602
6. Grey A, Mitnick M, Shapses S, Ellison A, Gundberg C, Insogna KL 1996 Circulating levels of interleukin-6 and tumor necrosis factor-α are elevated in primary hyperparathyroidism and correlate with markers of bone resorption - A clinical research center study. J Clin Endocrinol Metab 81:3450-3454
7. Grey A, Mitnick M, Masiukiewicz U, Sun BH, Rudikoff S, Jilka RL, Manolagas SC, Insogna KL 1999 A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140:4683-4690
8. Mallette L, Tuma S, Berger R, Kirkland J 1982 Radioimmunoassay for the middle region of human parathyroid hormone using an homologous anti-serum with a carboxy-terminal fragment of bovine parathyroid hormone as radioligand. J Clin Endocrinol Metab 54:1017-1024
9. Reinhardt T, Horst R, Orf J, Hollis B 1984 A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: Application to clinical studies. J Clin Endocrinol Metab 58:91-98
10. Godsall J, Burtis W, Insogna K, Broadus A, Stewart A 1986 Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy. Recent Prog Horm Res 42:705-750
11. Kerstetter J, Caseria D, Mitnick M, Ellison AF, Gay LF, Liskov TA, Carpenter TO, Insogna KL 1997 Increased circulating concentrations of parathyroid hormone in healthy, young women consuming a protein-restricted diet. Am J Clin Nutr 66:1188-1196
12. Broadus A 1979 Nephrogenous cyclic AMP as a parathyroid function test. Nephron 23:136-141
13. Gundberg CM, Hauschka PV, Liam JB, Gallup PM 1984 Osteocalcin: Isolation, characterization and detection. In: Moldave K, ed. Methods in Enzymology. New York: Academic; 516-544
14. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T 1993 Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA 90:11924-11928
15. Marcus R, Madvig P, Crim M, Pont A, Kosek J 1983 Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism. Ann Intern Med 100:633-640
16. Masiukiewicz U, Mitnick M, Grey A, Insogna K 2000 Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro. Endocrinology 141:2526-2531
17. Masiukiewicz U, Mitnick M, Gulanski B, Insogna K 2002 Evidence that the IL-6/IL-6 soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women. J Clin Endocrinol Metab 87:2892-2898
18. Lin S, Yamate T, Taguchi Y, Borba VZ, Girasole G, O'Brien CA, Bellido T, Abe E, Manolagas SC 1997 Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest 100:1980-1990
19. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel M, Ziegler R, Pfeilschifter J 2001 Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 86:2023-2042
20. Abrahamsen B, Bopnnevie-Nielsen V, Nils Ebbesen E, Gram J, Beck-Nielsen H 2000 Cytokines and bone loss in a 5-year longitudinal study-hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study. J Bone Miner Res 15:1545-1554
21. Mitnick M, Grey A, Masiukiewicz U, Bartkicwicz M, Rios-Velez L, Friedman S, Xu L, Horowitz M, Insogna KL 2001 Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiol 280:E405-E412
22. Kudo O, Sabokbar A, Itonaga L, Fujikawa Y, Torisu T, Athanasou N 2001 Human osteoclast formation and bone resorption by a mechanism independent of RANK/RANKL: Role of IL-6 and IL-11. J Bone Miner Res 16(Suppl 1):S381
23. Dai J, Lin D, Zhang J, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET 2000 Chronic alcohol ingestion induces osteoctastogenesis and bone loss through IL-6 in mice. J Clin Invest 106:887-895
24. Menaa C, Reddy S, Kurihara N, Maeda H, Anderson D, Cundy T, Cornish J, Singer F, Bruder J, Roodman GD 2000 Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest 105:1833-1838